`571-272-7822
`
`
`
`Paper 22
`Entered: April 19, 2018
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`____________
`
`Case IPR2017-02031
`Case IPR2017-02032
`Patent 6,407,213 B11
`____________
`
`
`Before SHERIDAN K. SNEDDEN, ZHENYU YANG, and
`ROBERT A. POLLOCK, Administrative Patent Judges.
`
`POLLOCK, Administrative Patent Judge.
`
`REVISED SCHEDULING ORDER
`
`
`1 This Order addresses issues that are common to each of the above-
`referenced cases. We exercise our discretion to issue one Order to be filed
`in each case. The parties are not authorized to use this style of heading.
`
`
`
`IPR2017-02031
`IPR2017-02032
`Patent 6,407,213 B1
`
`
`The Appendix to this Order sets due dates for the parties to take action
`
`after institution of these proceedings. The parties may stipulate to different
`
`dates for DUE DATES 1 through 5 (earlier or later, but no later than DUE
`
`DATE 6). A notice of the stipulation, specifically identifying the changed
`
`due dates, must be promptly filed. The parties may not stipulate to an
`
`extension of DUE DATE 6 or to any change in DUE DATE 7. In addition,
`
`even if the parties stipulate to an extension of DUE DATE 4, any request for
`
`oral hearing must still be filed on or before the date set forth in this Order, to
`
`provide sufficient time for the Board to accommodate the hearing.
`
`In stipulating to different times, the parties should consider the effect
`
`of the stipulation on times to object to evidence (37 C.F.R. § 42.64(b)(1)), to
`
`supplement evidence (37 C.F.R. § 42.64(b)(2)), to conduct cross-
`
`examination (37 C.F.R. § 42.53(d)(2)), and to draft papers depending on the
`
`evidence and cross-examination testimony (see Section D, below).
`
`The parties are reminded that the Testimony Guidelines appended to
`
`the Office Patent Trial Practice Guide, 77 Fed. Reg. 48,756, 48,772 (Aug.
`
`14, 2012) (Appendix D), apply to this proceeding. The Board may impose
`
`an appropriate sanction for failure to adhere to the Testimony Guidelines.
`
`37 C.F.R. § 42.12. For example, reasonable expenses and attorneys’ fees
`
`incurred by any party may be levied on a person who impedes, delays, or
`
`frustrates the fair examination of a witness.
`
`A. INITIAL CONFERENCE CALL
`
`The parties are directed to contact the Board within a month of this
`
`Order if there is a need to discuss proposed changes to this Order or
`
`proposed motions. See Office Patent Trial Practice Guide, 77 Fed. Reg.
`
`
`
`
`2
`
`
`
`Case IPR2017-02031
`Case IPR2017-02032
`Patent 6,407,213 B1
`
`48,756, 48,765–66 (Aug. 14, 2012) (guidance in preparing for the initial
`
`conference call).
`
`B. PROTECTIVE ORDER
`
`1. Confidential Information
`
`The parties must file confidential information using the appropriate
`
`availability indicator in PTAB E2E, regardless of whose confidential
`
`information it is. It is the responsibility of the party whose confidential
`
`information is at issue, not necessarily the proffering party, to file the motion
`
`to seal.
`
`A protective order does not exist in a case until one is filed in the case
`
`and is approved by the Board. If a motion to seal is filed by either party, the
`
`proposed protective order should be presented as an exhibit to the motion.
`
`The motion to seal must include a certification that the moving party has in
`
`good faith conferred or attempted to confer with other affected parties in an
`
`effort to resolve any dispute. See 37 C.F.R. 42.54(a).
`
`The parties are urged to operate under the Board’s default protective
`
`order, should that become necessary. See Default Protective Order, Office
`
`Patent Trial Practice Guide, 77 Fed. Reg. at 48,769–71, App. B.
`
`If the parties choose to propose a protective order deviating from the
`
`default protective order, they should submit the proposed protective order
`
`jointly. A marked-up comparison of the proposed and default protective
`
`orders should be presented as an additional exhibit to the motion to seal, so
`
`
`
`
`3
`
`
`
`Case IPR2017-02031
`Case IPR2017-02032
`Patent 6,407,213 B1
`
`that differences can be understood readily. The parties should contact the
`
`Board if they cannot agree on the terms of the proposed protective order.
`
`2. Redactions
`
`Redactions should be limited strictly to isolated passages consisting
`
`entirely of confidential information. The thrust of the underlying argument
`
`or evidence must be clearly discernable from the redacted version.
`
`3. Confidential Information in Final Written Decisions
`
`Information subject to a protective order will become public if
`
`identified in a final written decision in this proceeding. A motion to
`
`expunge the information will not prevail necessarily over the public interest
`
`in maintaining a complete and understandable file history. See Office Patent
`
`Trial Practice Guide, 77 Fed. Reg. at 48,761.
`
`C. DUE DATES
`
`1. DUE DATE 1
`
`The patent owner may file—
`
`a.
`
`b.
`
`A response to the petition (37 C.F.R. § 42.120), and
`
`A motion to amend the patent (37 C.F.R. § 42.121).
`
`The patent owner must file any such response or motion to amend by
`
`DUE DATE 1. If the patent owner elects not to file anything, the patent
`
`owner must arrange a conference call with the parties and the Board. The
`
`patent owner is cautioned that any arguments for patentability not raised in
`
`the response will be deemed waived.
`
`
`
`
`4
`
`
`
`Case IPR2017-02031
`Case IPR2017-02032
`Patent 6,407,213 B1
`
`
`2. DUE DATE 2
`
`The petitioner must file any reply to the patent owner’s response and
`
`opposition to the motion to amend by DUE DATE 2.
`
`3. DUE DATE 3
`
`The patent owner must file any reply to the petitioner’s opposition to
`
`patent owner’s motion to amend by DUE DATE 3.
`
`4. DUE DATE 4
`
`a.
`
`Each party must file any observations on the cross-examination
`
`testimony of a reply witness (see section E, below) by DUE DATE 4.
`
`b.
`
`Each party must file any motion to exclude evidence (37 C.F.R
`
`§ 42.64(c)) by DUE DATE 4.
`
`c. Each party must file any request for oral argument (37 C.F.R.
`
`§ 42.70(a)) by DUE DATE 4. As noted above, DUE DATE 4 is not
`
`extendible with respect to any request for oral argument.
`
`5. DUE DATE 5
`
`a.
`
`Each party must file any response to an observation on cross-
`
`examination testimony by DUE DATE 5.
`
`b.
`
`Each party must file any opposition to a motion to exclude
`
`evidence by DUE DATE 5.
`
`6. DUE DATE 6
`
`Each party must file any reply for a motion to exclude evidence by
`
`DUE DATE 6.
`
`
`
`
`5
`
`
`
`Case IPR2017-02031
`Case IPR2017-02032
`Patent 6,407,213 B1
`
`
`7. DUE DATE 7
`
`The oral argument (if requested by either party) is set for DUE
`
`DATE 7.
`
`D. CROSS-EXAMINATION
`
`Except as the parties might otherwise agree, for each due date—
`
`1.
`
`Cross-examination begins after any supplemental evidence is
`
`due. 37 C.F.R. § 42.53(d)(2).
`
`2.
`
`Cross-examination ends no later than a week before the filing
`
`date for any paper in which the cross-examination testimony is expected to
`
`be used. Id.
`
`E. OBSERVATIONS ON CROSS-EXAMINATION
`
`Observations on cross-examination provide the parties with a
`
`mechanism to draw the Board’s attention to relevant cross-examination
`
`testimony of a reply witness because no further substantive paper is
`
`permitted after the reply. See Office Patent Trial Practice Guide, 77 Fed.
`
`Reg. at 48,768 (Aug. 14, 2012). The observation must be a concise
`
`statement of the relevance of precisely identified testimony to a precisely
`
`identified argument or portion of an exhibit. Each observation should not
`
`exceed a single, short paragraph. The opposing party may respond to the
`
`observation. Any response must be equally concise and specific.
`
`F. MOTION TO AMEND
`
`
`
`The Federal Circuit’s Aqua Products decision instructs us to “assess[]
`
`the patentability of the proposed substitute claims without placing the
`
`burden of persuasion on the patent owner.” Aqua Products v. Matal, 872
`
`
`
`
`6
`
`
`
`Case IPR2017-02031
`Case IPR2017-02032
`Patent 6,407,213 B1
`
`F.3d 1290, 1328. Consistent with Guidance issued by the Chief Judge, the
`
`statutory and regulatory requirements for a motion to amend under
`
`35 U.S.C. § 316(d) and 37 C.F.R. § 42.121, as well as the duty of candor
`
`under 37 C.F.R. § 42.11, remain applicable. See “Guidance on Motions to
`
`Amend in view of Aqua Products”
`
`(https://www.uspto.gov/sites/default/files/documents/guidance_on_motions_
`
`to_amend_11_2017.pdf) (Nov. 21, 2017).
`
`The patent owner must confer with the Board before filing any
`
`Motion to Amend. See 37 C.F.R. § 42.121(a). A conference call to satisfy
`
`the requirement of 37 C.F.R. § 42.121(a) must be scheduled no less than ten
`
`(10) business days prior to DUE DATE 1, and preferably within one month
`
`of this Order.
`
`
`
`G. COMMUNICATIONS WITH THE BOARD
`
`Except as otherwise provided in the Rules, Board authorization is
`
`required before filing a motion. 37 C.F.R. § 42.20(b). A party seeking to file
`
`a non-preauthorized motion should request a conference to obtain
`
`authorization to file the motion. Parties may request a conference with us by
`
`contacting the Board staff by e-mail at Trials@uspto.gov or by telephone at
`
`571-272-7822.
`
`Regarding discovery disputes, the parties are encouraged to resolve
`
`such issues on their own and in accordance with the precepts set forth in 37
`
`C.F.R. § 42.1(b). To the extent that a dispute arises between the parties
`
`relating to discovery, the parties should meet and confer to resolve such a
`
`dispute before contacting the Board. If attempts to resolve the dispute fail, a
`
`party may request a conference call with the Board and the other party to
`
`
`
`
`7
`
`
`
`Case IPR2017-02031
`Case IPR2017-02032
`Patent 6,407,213 B1
`
`discuss the issue and, if necessary, seek authorization to file a motion in that
`
`regard. An email requesting a conference call shall: (a) copy the other party,
`
`(b) indicate generally the subject matter of the conference call and relief
`
`requested, (c) state whether the opposing party opposes the request, and (d)
`
`include multiple times when all parties are available for a conference. The
`
`email shall not contain substantive argument.
`
`DUE DATE APPENDIX
`
`DUE DATE 1 .................................................................. June 26, 2018
`
`Patent owner’s response to the petition
`
`Patent owner’s motion to amend the patent
`
`DUE DATE 2 .......................................................... September 18, 2018
`
`Petitioner’s reply to patent owner’s response to petition
`
`Petitioner’s opposition to motion to amend
`
`DUE DATE 3 ..............................................................October 16, 2018
`
`Patent owner’s reply to petitioner’s opposition to motion to amend
`
`DUE DATE 4 ............................................................ November 6, 2018
`
`Observations regarding cross-examination of reply witness
`
`Motion to exclude evidence
`
`Request for oral argument
`
`DUE DATE 5 ........................................................... November 20, 2018
`
`Response to observations
`
`Opposition to motion to exclude
`
`
`
`
`8
`
`
`
`Case IPR2017-02031
`Case IPR2017-02032
`Patent 6,407,213 B1
`
`DUE DATE 6 ......................................................... November 27, 2018
`Reply to opposition to motion to exclude
`
`DUE DATE 7 .......................................................... December 13, 2018
`Oral argument (if requested).
`
`
`
`
`9
`
`
`
`Case IPR2017-02031
`Case IPR2017-02032
`Patent 6,407,213 B1
`
`PETITIONER:
`
`Ire J. Levy
`Brian A. Fairchild
`GOODWIN PROCTER LLP
`ilevy@goodwinlaw.com
`bfairchild@goodwinlaw.com
`
`
`PATENT OWNER:
`
`David L. Cavanaugh
`Rebecca A. Whitfield
`WILMER CUTLER PICKERING HALE AND DORR LLP
`david.cavanaugh@wilmerhale.com
`Rebecca.Whitfield@wilmerhale.com
`
`
`Adam R. Brausa
`DURIE TANGRI LLP
`abrausa@durietangri.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`10
`
`